May 20, 2018

US District Court rejects Dr Reddy's Laboratories patent

17 February 2017, 11:59 | Melvin Schneider

Dr Reddy's said it did not infringe three of the claims, adding that the remaining ten were invalid but that it would have infringed them should they be found valid. The Swiss company said these drug makers infringed its patent by filing a new drug application and abbreviated new drug application with the regulator to market and sell generic versions of Aloxi, used to prevent nausea and vomiting in chemotherapy patients.

The pharmaceutical company has declared that the United States District Court for the District of New Jersey issued its opinion regarding Helsinn Healthcare patent infringement.

Drug major Dr Reddy's Laboratories on Friday said there are no claims against the company for monetary damages after it received an unfavourable ruling in a U.S. court regarding a patent infringement case over anti-nausea injection Aloxi. "7,947, 8,729,094 and 9,066,980, and that the asserted claims of '094 patents were not valid". "Helsinn Healthcare filed an infringement claims against DRL's proposed palonosetron product, pursuant to a 'paper" NDA under section 505 (b) (2) of the Food, Drug and Cosmetic Act.

The drug is estimated to have a market size of almost $500 million in the U.S., Surajit Pal, analyst, Prabhudas Lilladher told BloombergQuint.

French FM says U.S. position on Mideast peace 'confusing'
Lindsey Graham, who said despite disagreements on some issues he never doubted the nominee's commitment to Israel. Friedman attacked J Street in December after the group said it was " vehemently opposed " to his nomination.

Pak asks Afghanistan to immediately handover 76 wanted terrorists
The security officials believe that militant groups now operate from the Afghanistan border region to launch attacks in Pakistan. Police said that a suicide bomber entered the Lal Shehbaz Qalandar shrine in Sehwan town of Sindh through its Golden Gate.

Port Authority Approves $3.5 Billion to Replace Bus Terminal
The plan outlines specific funding commitments for major capital projects the agency will invest in over the next 10 years. The approval followed a month-long public comment process where hundreds of people submitted written or oral testimony.

A favourable ruling would have allowed Dr. Reddy's to replace the patented drug, which has an estimated size of $650 million in the US market, say analysts.

The company said it intends to pursue an appeal in due course of time. Later, DRL received an approval from the USFDA for generic Aloxi in March 2016 after it settled patent litigations relating to its anti-nausea injection Aloxi.

Please Wait while comments are loading.

Other News

Trending Now

Trump apparently doesn't know how many Electoral College votes he got
Trump's wasn't even the biggest win since Barack Obama. "I was given that information, I don't know", Trump replied. He did beat George W Bush, however, who only won 271 electoral votes in 2000 and 286 in 2004. "I don't know.

Keystone XL Pipeline Proposal Reawakened With Nebraska Application
The $8 billion dollar pipeline would carry crude from the oil sands of western Canada to refineries along the Gulf Coast in Texas. President Donald Trump took office last month, he said TransCanada was welcome to resubmit an application to build the pipeline.

Dunford to Meet With Russian Chief of General Staff
This was the first face-to-face meeting between the two top seniors of the world's two greatest military powers. Despite the latest safety effort, U.S.

Google CEO responds to 7-year-old who wants job
When Chloe decided she wanted to work there, too, her father encouraged her to apply and "get the ball rolling", he said. Chloe, who is passionate about robots and computers, sent the letter to Google's offices in Silicon Valley last Monday.